您的位置: 首页 > 2023年3月 第54卷 第3期 > 文字全文
2023年7月 第38卷 第7期11
目录

心脏康复治疗对心房颤动合并高血压患者的影响

Effect of cardiac rehabilitation on patients with atrial fibrillation and hypertension

来源期刊: 广州医药 | 41-47 发布时间:2023-04-14 收稿时间:2025/11/13 18:37:08 阅读量:30
作者:
关键词:
心房颤动高血压运动康复
atrial fibrillationhypertensionexercisecardiac rehabilitation
DOI:
10.3969/j.issn.1000-8535.2023.03.008
收稿时间:
2022-03-30 
修订日期:
 
接收日期:
 
引用总数:
8  
目的 探索心脏康复干预对房颤合并高血压患者的血脂血压变化、运动耐量、心脏功能、肺功能等指标的影响。方法 选取房颤合并高血压患者96例,随机分为常规治疗组和心脏康复(CR)组,每组各48例患者。常规治疗组给予规范的药物治疗,CR组在规范药物治疗的基础上予运动干预6个月,对比治疗前后2组甘油三酯(TG)、总胆固醇(TC)、低密度脂蛋白(LDL-C)水平,左心房直径(LA)、左心室射血分数(LVEF)、左心室舒张末内径(LVEDd),无氧阈值(AT)、峰值公斤摄氧量(PeakVO2/kg)、峰值通气量(VEpeak)、每搏输出量(SV)、峰值氧脉搏(PeakO2pluse),收缩压(SBP)与舒张压(DBP)变化情况,6分钟步行距离(6MWD),以及Borg劳累评估量表评分、焦虑自评量表(SAS)和抑郁自评量表(SDS)评分。结果 2组患者治疗6个月时,TC、TG、LDL-C水平以及SBP、DBP均下降(P<0.05),但2组之间比较,3项血脂指标无统计学差异(P>0.05),而CR组血压显著下降(P<0.05) 。2组患者治疗6个月时,LA、LVEDd减小(P<0.05),而LVEF无变化(P>0.05),CR组LA较常规治疗组缩小(P<0.05)。治疗6个月时,CR组AT、PeakVO2/kg、VEpeak、SV和PeakO2plus水平均升高(P<0.05),而常规治疗组的上述相关指标无明显变化(P>0.05)。治疗6个月时,2组患者6分钟步行距离均增加,CR组较常规组增加(P<0.05)。治疗6个月时,CR组Borg劳累评估量表评分、SAS评分及SDS评分均下降,而常规治疗组上述3项评分较治疗前无变化(P>0.05),与常规治疗组比较,CR组上述3项评分降低(P<0.05)。结论 以中等强度运动干预为主导的心脏康复治疗能够降低房颤合并高血压患者的血脂水平、控制血压状态、改善左心房及左心室结构重构,还可以增加该群体的运动耐力及心肺功能、减少消极情绪并提高生活质量。
Objective To evaluate the impact of cardiac rehabilitation on blood lipid level,blood pressure control,exercise endurance,cardiac function, quality of life and lung function in patients with hypertension and atrial fibrillation (AF). Methods This prospective cohort study enrolled 96 patients with AF and hypertension, who were randomly and evenly assigned to the conventional group and the cardiac rehabilitation (CR) group, both treated for at least 6 months. Research indicators included the levels of triglycerides (TG), total cholesterol (TC) and low density lipoprotein cholesterol (LDL-C); left atrial diameter (LA), left ventricular ejection fraction (LVEF), left ventricular end diastolic diameter (LVEDd), anaerobic threshold (AT), peak oxygen uptake volume per kilogram (PeakVO2/kg), peak ventilation volume (VEpeak), stroke volume (SV), peak oxygen pulse (PeakO2pluse), changes in blood pressure, 6 minutes walking distance, Borg Fatigue Scale score, Self-Rating Anxiety Scale (SAS) and Self-Rating Depression Scale (SDS) scores. Results At the 6th month of the treatment, the levels of TG, TC, LDL-C, systolic blood pressure (SBP), diastolic blood pressure (DBP) were significantly reduced (P<0.05) in both groups. However, there was no statistical difference among the three blood lipid indicators between the conventional group and the CR group after treatment (P>0.05). Blood pressure dropped significantly(P<0.05) in both groups, especially in the CR group. Meanwhile, after treatment, LA and LVEDd decreased significantly (P<0.05) in both groups, except LVEF. LA decreased significantly (P<0.05) in CR group, compared with conventional group. In addition, AT, PeakVO2/kg, VEpeak, SV and PeakO2pluse levels were significantly elevated (P<0.05) in CR group compared with the conventional group after the treatment. There was no significant difference (P>0.05) in the indicators above in the conventional group. Six minutes walking distance were significantly increased (P<0.05) in both groups at 6th month of treatment, compared with the conventional group, the CR group increased more (P<0.05). Borg Fatigue Scale score, SAS score and SDS score were significantly reduced (P<0.05) in CR group at 6th month of treatment, however, there was no statistical difference (P>0.05) in the conventional group compared with that before treatment. The scores above were significantly reduced (P<0.05) in CR group compared with the conventional group after the treatment. Conclusions Cardiac rehabilitation therapy dominated by moderate-intensity exercise intervention can reduce the blood lipid level of atrial fibrillation and hypertension patients, control the blood pressure, improve the left atrial and left ventricular structure reconstruction, increase the exercise endurance, improve cardiopulmonary function, reduce negative emotions and improve the quality of life.
1、 李晗,冯茹,陈红琢,等.运动训练在心力衰竭患者心脏康复中的研究进展[J].中国康复,2020,35(4):208-211. 李晗,冯茹,陈红琢,等.运动训练在心力衰竭患者心脏康复中的研究进展[J].中国康复,2020,35(4):208-211.
2、 DECATO T W, HAVERKAMP H, HEGEWALD M J.Cardiopulmonary exercise testing (CPET)[J].Am J Respir Crit Care Med,2020,201(1):P1-P2. DECATO T W, HAVERKAMP H, HEGEWALD M J.Cardiopulmonary exercise testing (CPET)[J].Am J Respir Crit Care Med,2020,201(1):P1-P2.
3、 彭夏锋,李库林,王如兴,等.二维斑点追踪对房颤所致的左房重构及房颤相关疾病发生的评估[J].江苏大学学报(医学版),2019,29(5):451-455. 彭夏锋,李库林,王如兴,等.二维斑点追踪对房颤所致的左房重构及房颤相关疾病发生的评估[J].江苏大学学报(医学版),2019,29(5):451-455.
4、 刘顺民,王顺楷,徐顺霖,等.心脏康复运动训练持续时间对介入治疗后冠心病患者心肺功能、运动能力及内皮细胞功能的影响研究[J].实用心脑肺血管病杂志,2019,27(2):115-118. 刘顺民,王顺楷,徐顺霖,等.心脏康复运动训练持续时间对介入治疗后冠心病患者心肺功能、运动能力及内皮细胞功能的影响研究[J].实用心脑肺血管病杂志,2019,27(2):115-118.
5、 QIU D, PENG L, GHISTA D N, et al. Left atrial remodeling mechanisms associated with atrial fibrillation[J].Cardiovasc Eng Technol, 2021,12(3):361-372. QIU D, PENG L, GHISTA D N, et al. Left atrial remodeling mechanisms associated with atrial fibrillation[J].Cardiovasc Eng Technol, 2021,12(3):361-372.
6、 BARONE GIBBS B, HIVERT M F, JEROME G J,et al. Physical activity as a critical component of first line treatment for elevated blood pressure or cholesterol: who, what, and how?A scientific statement from the American Heart Association[J].Hypertension,2021,78(2):e26-e37. BARONE GIBBS B, HIVERT M F, JEROME G J,et al. Physical activity as a critical component of first line treatment for elevated blood pressure or cholesterol: who, what, and how?A scientific statement from the American Heart Association[J].Hypertension,2021,78(2):e26-e37.
7、 S'WIATKIEWICZ I, DI SOMMA S, de FAZIO L, et al.Effectiveness of intensive cardiac rehabilitation in high-risk patients with cardiovascular disease in real-world practice[J].Nutrients, 2021,13(11):3883. S'WIATKIEWICZ I, DI SOMMA S, de FAZIO L, et al.Effectiveness of intensive cardiac rehabilitation in high-risk patients with cardiovascular disease in real-world practice[J].Nutrients, 2021,13(11):3883.
8、 张苗苗,陈桂英,胡大一,等.运动在心房颤动康复中作用的研究进展[J].中国心血管病研究,2020,18(10):932-935. 张苗苗,陈桂英,胡大一,等.运动在心房颤动康复中作用的研究进展[J].中国心血管病研究,2020,18(10):932-935.
9、 BUCKLEY B J R, HARRISON S L, FAZIO-EYNULLAYEVA E, et al. Exercise-based cardiac rehabilitation and all-cause mortality among patients with atrial fibrillation[J].J Am Heart Assoc, 2021, 10(12):e020804. BUCKLEY B J R, HARRISON S L, FAZIO-EYNULLAYEVA E, et al. Exercise-based cardiac rehabilitation and all-cause mortality among patients with atrial fibrillation[J].J Am Heart Assoc, 2021, 10(12):e020804.
10、 MESSORI A, BARTOLI L, FERRACANE E, et al.Medical therapy, radiofrequency ablation or cryoballoon ablation as first-line treatment for paroxysmal atrial fibrillation: interpreting efficacy through restricted mean survival time and network meta-analysis[J].Rev Cardiovasc Med,2021,22(3):557-561. MESSORI A, BARTOLI L, FERRACANE E, et al.Medical therapy, radiofrequency ablation or cryoballoon ablation as first-line treatment for paroxysmal atrial fibrillation: interpreting efficacy through restricted mean survival time and network meta-analysis[J].Rev Cardiovasc Med,2021,22(3):557-561.
11、 中国康复医学会心血管病专业委员会.中国心脏康复与二级预防指南2018精要[J].中华内科杂志,2018,57(11):802-810. 中国康复医学会心血管病专业委员会.中国心脏康复与二级预防指南2018精要[J].中华内科杂志,2018,57(11):802-810.
12、 中国康复医学会心血管病预防与康复专业委员会.心房颤动患者心脏康复中国专家共识[J].中华内科杂志,2021,60(2):106-116. 中国康复医学会心血管病预防与康复专业委员会.心房颤动患者心脏康复中国专家共识[J].中华内科杂志,2021,60(2):106-116.
13、 OTT C, SCHMIEDER R E.Diagnosis and treatment of arterial hypertension 2021[J].Kidney Int,2022, 101(1):36-46. OTT C, SCHMIEDER R E.Diagnosis and treatment of arterial hypertension 2021[J].Kidney Int,2022, 101(1):36-46.
14、 陈东学,初金泽,孙磊,等.运动与心房颤动相互关系的研究进展[J].临床内科杂志,2020,37(12):892-894. 陈东学,初金泽,孙磊,等.运动与心房颤动相互关系的研究进展[J].临床内科杂志,2020,37(12):892-894.
15、 ROBAYE B,LAKISS N,DUMONT F, et al. Atrial fibrillation and cardiac rehabilitation:an overview[J].Acta Cardiol,2020,75(2):116-120. ROBAYE B,LAKISS N,DUMONT F, et al. Atrial fibrillation and cardiac rehabilitation:an overview[J].Acta Cardiol,2020,75(2):116-120.
16、 GOROG D A, GUE Y X, CHAO T F, et al. Assessment and mitigation of bleeding risk in atrial fibrillation and venous thromboembolism: A position paper from the ESC working group on thrombosis, in collaboration with the european heart rhythm association, the association for acute cardiovascular care and the asia-pacific heart rhythm society[J].Europace,2022: euac020. GOROG D A, GUE Y X, CHAO T F, et al. Assessment and mitigation of bleeding risk in atrial fibrillation and venous thromboembolism: A position paper from the ESC working group on thrombosis, in collaboration with the european heart rhythm association, the association for acute cardiovascular care and the asia-pacific heart rhythm society[J].Europace,2022: euac020.
1、王新敏. 沙库巴曲缬沙坦联合胺碘酮对高血压伴阵发性心房颤动患者左心室功能及窦性心律维持率的影响[J]. 反射疗法与康复医学,2023,4(10):102-105.王新敏. 沙库巴曲缬沙坦联合胺碘酮对高血压伴阵发性心房颤动患者左心室功能及窦性心律维持率的影响[J]. 反射疗法与康复医学,2023,4(10):102-105.
2、王丽,鲁燕.心房颤动康复的综合管理[J].实用心电学杂志,2023,32(03):177-182.DOI:10.13308/j.issn.2095-9354.2023.03.006. 王丽,鲁燕.心房颤动康复的综合管理[J].实用心电学杂志,2023,32(03):177-182.DOI:10.13308/j.issn.2095-9354.2023.03.006.
3、宁晓云,姜雅,顾振杰.目前心肺康复在冠心病治疗和预防中的研究进展[J].中外医疗,2023,42(27):195-198.DOI:10.16662/j.cnki.1674-0742.2023.27.195. 宁晓云,姜雅,顾振杰.目前心肺康复在冠心病治疗和预防中的研究进展[J].中外医疗,2023,42(27):195-198.DOI:10.16662/j.cnki.1674-0742.2023.27.195.
4、游展鸿,汤志杰,王洁,等.心房颤动患者运动康复随机对照试验研究结局指标的范围综述[J].中华现代护理杂志,2024,30(27):3768-3776. 游展鸿,汤志杰,王洁,等.心房颤动患者运动康复随机对照试验研究结局指标的范围综述[J].中华现代护理杂志,2024,30(27):3768-3776.
5、陈晨,李林,陈世超.加速康复外科护理在心房颤动行导管射频消融术患者中的应用效果[J].中国民康医学,2025,37(06):161-163. 陈晨,李林,陈世超.加速康复外科护理在心房颤动行导管射频消融术患者中的应用效果[J].中国民康医学,2025,37(06):161-163.
6、闫龙美,陈可冀,邢雅璇,等.基于“木郁达之”探析高血压合并心房颤动辨证治疗思路[J].世界中西医结合杂志,2025,20(03):615-620.DOI:10.13935/j.cnki.sjzx.250333. 闫龙美,陈可冀,邢雅璇,等.基于“木郁达之”探析高血压合并心房颤动辨证治疗思路[J].世界中西医结合杂志,2025,20(03):615-620.DOI:10.13935/j.cnki.sjzx.250333.
7、连雅萍.高龄心房颤动并高血压病患者血压管理现状及干预对策[J].心血管病防治知识,2025,15(08):57-60. 连雅萍.高龄心房颤动并高血压病患者血压管理现状及干预对策[J].心血管病防治知识,2025,15(08):57-60.
上一篇
下一篇
出版者信息








《广州医药》公众号
目录